Polycystic Ovarian Syndrome/Disease’ is abbreviated as PCOS/PCOD respectively. PCOS/ PCOD is a heterogenous, multisystem endocrinopathy in women of reproductive age with the ovarian expression of metabolic disturbances and a wide diapason of clinical features similar as, hyperinsulinemia, menstrual abnormalities (Oligomenorrhea, Amenorrhoea/Anovulation) and hyperandrogenism. PCOS, also known as Stein- Leventhal pattern (the first to recognize an association between polycystic ovaries and signs of hirsutism and amenorrhoea), is an endocrine complaint primarily affecting individualities with female reproductive systems. It is illustrated by hyperandrogenism, oligomenorrhea or amenorrhea, and polycystic ovarian morphology observed on medical imaging. PCOS is associated with insulin resistance and frequently leads to irregular menstrual cycles, anovulation, and an increased threat of metabolic disturbances, including rotundity, type 2 diabetes, and cardiovascular complications. Its aetiology is multifactorial, involving complex inheritable, hormonal, and environmental factors. Opinion generally relies on specific clinical and laboratory criteria, and operation strategies encompass life variations, hormonal curatives, and addressing associated comorbidities.
‘Hypothyroidism’ is a widely discussed term these days in medical field owing to its affection which involves different organ system and hypometabolism. Also the cardiac and OBG complications wrapped as an essential prognosis makes its management even more controversial. The adequate clinical examination, intricate investigative measures with proper screening leads to well established diagnosis of the above. The survey report study suggests, around 1.8% of the population is affected by it, which positions it almost 2nd to DM in terms of endocrine disorders.